Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Walker

Showing results (101-110 of 137) with videos related to

Pageof 14
Sort By:
Oncotarget|October 15, 2017
Molecular profiling of colorectal pulmonary metastases and primary tumours: implications for targeted treatmentSing Y Moorcraft, Thomas Jones, Brian A Walker, et al.
Cancer Cell|September 13, 2017
Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 InhibitorsLaura Tornatore, Annamaria Sandomenico, Domenico Raimondo, et al.
Cancer Cell|October 15, 2014
Cancer-selective targeting of the NF-κB survival pathway with GADD45β/MKK7 inhibitorsLaura Tornatore, Annamaria Sandomenico, Domenico Raimondo, et al.
Oncotarget|January 18, 2018
Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumoursElisa Izquierdo, Lina Yuan, Sally George, et al.
Haematologica|December 7, 2014
The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cellsNiels Weinhold, Tobias Meissner, David C Johnson, et al.
Haematologica|February 9, 2019
Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patientsJohn R Jones, Niels Weinhold, Cody Ashby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2022
Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple MyelomaParvathi Sudha, Aarif Ahsan, Cody Ashby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple MyelomaEileen M Boyle, Patrick Blaney, James H Stoeckle, et al.
Blood|August 13, 2016
Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myelomaNiels Weinhold, Cody Ashby, Leo Rasche, et al.
British Journal of Haematology|June 21, 2019
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trialEileen M Boyle, Xavier Leleu, Marie-Odile Petillon, et al.
Pageof 14

Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
Oncotarget|October 15, 2017
Molecular profiling of colorectal pulmonary metastases and primary tumours: implications for targeted treatmentSing Y Moorcraft, Thomas Jones, Brian A Walker, et al.
Cancer Cell|September 13, 2017
Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 InhibitorsLaura Tornatore, Annamaria Sandomenico, Domenico Raimondo, et al.
Cancer Cell|October 15, 2014
Cancer-selective targeting of the NF-κB survival pathway with GADD45β/MKK7 inhibitorsLaura Tornatore, Annamaria Sandomenico, Domenico Raimondo, et al.
Oncotarget|January 18, 2018
Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumoursElisa Izquierdo, Lina Yuan, Sally George, et al.
Haematologica|December 7, 2014
The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cellsNiels Weinhold, Tobias Meissner, David C Johnson, et al.
Haematologica|February 9, 2019
Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patientsJohn R Jones, Niels Weinhold, Cody Ashby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2022
Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple MyelomaParvathi Sudha, Aarif Ahsan, Cody Ashby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple MyelomaEileen M Boyle, Patrick Blaney, James H Stoeckle, et al.
Blood|August 13, 2016
Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myelomaNiels Weinhold, Cody Ashby, Leo Rasche, et al.
British Journal of Haematology|June 21, 2019
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trialEileen M Boyle, Xavier Leleu, Marie-Odile Petillon, et al.
Pageof 14